Page last updated: 2024-08-21

cyclopentane and Adenocarcinoma Of Kidney

cyclopentane has been researched along with Adenocarcinoma Of Kidney in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeong, LS; Jia, L; Li, L; Liang, Y; Liu, L; Liu, X; Wang, J; Wang, S; Wang, X; Yu, J; Zhang, W; Zhang, Y; Zhao, H1
Jiang, W; Si, Y; Tong, S; Xie, P; Yu, H; Zhang, L1
Bi, R; Chang, J; Deng, Y; Du, Y; Guo, H; Liu, G; Shah, NK; Shu, C; Wang, C; Wei, W; Xu, B1
Cuffe, LP; Gallagher, WM; Lou, Y; Mendoza, O; Müller-Bunz, H; Rehmann, FJ; Sweeney, N; Tacke, M1

Other Studies

4 other study(ies) available for cyclopentane and Adenocarcinoma Of Kidney

ArticleYear
Targeting neddylation pathway with MLN4924 (Pevonedistat) induces NOXA-dependent apoptosis in renal cell carcinoma.
    Biochemical and biophysical research communications, 2017, 09-02, Volume: 490, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Survival; Cyclopentanes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Kidney Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Structure-Activity Relationship; Tumor Cells, Cultured; Up-Regulation

2017
MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma.
    Scientific reports, 2017, 07-17, Volume: 7, Issue:1

    Topics: Apoptosis; Autophagy; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cyclopentanes; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; NEDD8 Protein; Protein Processing, Post-Translational; Proteolysis; Pyrimidines; Tumor Cells, Cultured; Ubiquitins

2017
A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.
    Cancer chemotherapy and pharmacology, 2018, Volume: 81, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Cyclopentanes; DNA Damage; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Pyrimidines; Ubiquitin-Activating Enzymes; Ubiquitin-Conjugating Enzymes; Xenograft Model Antitumor Assays

2018
Methoxy-phenyl substituted ansa-titanocenes as potential anti-cancer drugs derived from fulvenes and titanium dichloride.
    Journal of inorganic biochemistry, 2004, Volume: 98, Issue:12

    Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cyclopentanes; Drug Evaluation, Preclinical; Inhibitory Concentration 50; Kidney Neoplasms; Molecular Conformation; Swine; Titanium

2004